Concepedia

Publication | Open Access

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network

DOIFull Paper Access

170

Citations

20

References

2016

Year

Hélène Vallet, P. Sève, Lucie Biard, Jean Baptiste Fraison, P. Bielefeld, Laurent Pérard, Boris Bienvenu, S. Abad, Aude Rigolet, Alban Deroux,
Arthritis & Rheumatology

Abstract

Anti-TNF treatment is highly effective in refractory inflammatory uveitis. BD is associated with increased odds of response. IFX and ADA appear to be equivalent in terms of efficacy.

References

YearCitations

Page 1